In Q3, Healthpeak demonstrated substantial leasing momentum, executing 465,000 square feet in lease agreements with life ...
Mizuho Securities analyst Vikram Malhotra has reiterated their bullish stance on DOC stock, giving a Buy rating today. Vikram Malhotra’s ...
Healthpeak Properties raised the lower-end of its annual funds from operations (FFO) forecast on Thursday, banking on steady demand for its medical office and life science properties.
Healthpeak Properties is a BBB+ rated healthcare REIT with a solid portfolio. Read what makes DOC stock a sound investment ...
Ronald Kamdem, an analyst from Morgan Stanley, maintained the Hold rating on Healthpeak Properties (DOC – Research Report). The ...
Healthpeak Properties, Inc. (NYSE: DOC), a leading owner, operator, and developer of real estate for healthcare discovery and delivery, today announce ...
Deutsche Bank upgraded Healthpeak Properties (NYSE:DOC) stock to Buy from Neutral on Monday to reflect an improved leasing ...
Throughout the last three months, 8 analysts have evaluated Healthpeak Properties DOC, offering a diverse set of opinions from bullish to bearish. The following table encapsulates their recent ...
Deutsche Bank analyst Omotayo Okusanya upgraded Healthpeak Properties (DOC) to Buy from Hold with a price target of $28, up from $20. The life sciences real estate market is “navigating a ...
Healthpeak Properties has a diversified portfolio with strong occupancy rates in MOBs and lab facilities. Read why DOC stock ...
Healthpeak Properties, Inc. DOC reported third-quarter 2024 funds from operations (FFO) as adjusted per share of 45 cents, ...